Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
63,819,650
-
Share change
-
+10,072,244
-
Total reported value
-
$215,650,821
-
Put/Call ratio
-
157%
-
Price per share
-
$3.38
-
Number of holders
-
107
-
Value change
-
+$33,681,613
-
Number of buys
-
53
-
Number of sells
-
47
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2021
As of 31 Dec 2021 CYMABAY THERAPEUTICS INC - COM (CBAY) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,819,650 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, TCG Crossover Management, LLC, COMMODORE CAPITAL LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, Nantahala Capital Management, LLC, DAFNA Capital Management LLC, and Foresite Capital Management IV, LLC.
This table shows 107 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.